We showed that GSDMD is activated by hyperoxia in the lungs and brains of neonatal mice and that treatment with a pharmacological inhibitor of GSDMD attenuated hyperoxia-induced BPD-like pathology and brain injury15. The gene discussed is GSDMD; the disease is bronchopulmonary dysplasia.